Intravitreal faricimab for neovascular age-related macular degeneration previously treated with traditional anti-VEGF compounds: a real-world prospective study
Gabriela Grimaldi, Giuseppe Cancian, Angelica Rizzato, Alex Casanova, Kathrin Perruchoud-Ader, Michele Clerici, Andrea Consigli, Moreno Menghini
Topics & Concepts
MedicineMacular degenerationRanibizumabAfliberceptProspective cohort studyConfidence intervalOphthalmologyClinical trialBevacizumabCohortSurgeryInternal medicineChemotherapyRetinal Diseases and TreatmentsOphthalmology and Visual Impairment StudiesRetinopathy of Prematurity Studies